Taysha Gene Therapies, INC. (TSHA) SEC Filings — 2024

Filings

• Taysha Gene Therapies, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Taysha Gene Therapies, INC. SC 13G Filing — SC 13G · Nov 14, 2024
• Taysha Gene Therapies Files 8-K — 8-K · Nov 13, 2024
• Taysha Gene Therapies Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Taysha Gene Therapies, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Taysha Gene Therapies, INC. SC 13G Filing — SC 13G · Nov 8, 2024
• Taysha Gene Therapies, INC. SC 13G Filing — SC 13G · Oct 22, 2024
• Taysha Gene Therapies Files 8-K — 8-K · Aug 12, 2024
• Taysha Gene Therapies Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
• Astellas to Acquire Taysha Gene Therapies for $1.1 Billion — 8-K · Jun 26, 2024
• Taysha Gene Therapies Files 8-K — 8-K · Jun 18, 2024
• Taysha Gene Therapies Files 8-K on Shareholder Vote Matters — 8-K · May 30, 2024
• Taysha Gene Therapies Files 8-K — 8-K · May 14, 2024
• Taysha Gene Therapies Q1 2024 Update — 10-Q · May 14, 2024
• Taysha Gene Therapies Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 18, 2024
• Taysha Gene Therapies Files 8-K — 8-K · Mar 19, 2024
• Taysha Gene Therapies Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
• Taysha Gene Therapies, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Taysha Gene Therapies, INC. SC 13G Filing — SC 13G · Feb 14, 2024
• TCG Crossover GP I Reports 0% Stake in Taysha Gene Therapies — SC 13G/A · Feb 9, 2024
• FMR LLC & Abigail Johnson Trim Taysha Gene Therapies Stake to 12.002% — SC 13G/A · Feb 9, 2024
• Taysha Gene Therapies Files 8-K for Reg FD Disclosure — 8-K · Jan 10, 2024